Type 2 & other diabetes

Diabetes mellitus and 10-year clinical outcomes after percutaneous coronary intervention with drug-eluting stents: insights from the DECADE cooperation

Cardiovasc DiabetolPublished Pooled analysis of five randomized controlled trials

Pooled result · All-cause deathResult — go to the resultAdjusted hazard ratio 1.68 95% CI 1.59–1.78

Authors' conclusion

DM was associated with distinct temporal patterns of adverse outcomes after PCI with DES, with an early associations with MI and definite ST, as well as an increased risk of death and repeat revascularisation in the longer term. These findings further emphasize the need for intensified secondary prevention and provide a long-term benchmark against which novel management strategies should be evaluated in patients with DM undergoing PCI.

Study context

Population
Patients treated with drug-eluting stents (drug-eluting stent (DES)) during percutaneous coronary intervention (PCI) in five randomized controlled trials with available 10-year follow-up, grouped by diabetes mellitus (DM) diagnosis at baselinepatients pooled
Participants
9,699 patients
Comparison
Patients with DM compared with patients without DM
  • DMn = 2,298
Outcome
All-cause death
Follow-up
Up to 10 years
Methodological details10-year follow-up, multivariable analyses, subgroup analyses, landmark analyses
  • 10-year follow-up
  • Multivariable analyses
  • Subgroup analyses
  • Landmark analyses

Pooled result

As reported in the abstract

Adjusted hazard ratio

1.68

95% CI 1.59–1.78

DMvs NO DM
HRadj 1.68 (95% CI 1.59–1.78)

Further pooled results

OutcomeHRadj (CI)
Cardiovascular death · up to 10 years1.74 (1.63–1.87)
Definite ST1.55 (1.18–2.04)
TLR1.35 (1.21–1.51)
TVR1.28 (1.14–1.43)
nTVR1.23 (1.09–1.40)

Landmark analyses

The excess myocardial infarction (MI) risk was predominantly observed within the first month
The excess definite stent thrombosis (ST) risk was detected between 30 days and 1 year

Subgroups by age, sex, clinical presentation, and DES-generation

Association between DM at baseline and clinical outcomes varied across subgroups
  • All Pinteraction <0.001

Insulin-treated patients

Insulin-treated patients represent the higher risk phenotype

Original publication

Diabetes mellitus and 10-year clinical outcomes after percutaneous coronary intervention with drug-eluting stents: insights from the DECADE cooperation. Cardiovasc Diabetol. Published 11 November 2026. doi:10.1186/s12933-026-03434-3

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.